Figure 2

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 31, Supplement—October 2025

SUPPLEMENT ISSUE

Nonspecific Symptoms Attributable to Lyme Disease in High-Incidence Areas, United States, 2017–2021

Courtney C. Nawrocki, Mark J. Delorey, Austin R. Earley, Sarah A. Hook, Kiersten J. Kugeler, Grace E. Marx, Paul S. Mead, and Alison F. Hinckley

Author affiliation: Centers for Disease Control and Prevention, Fort Collins, Colorado, USA (C.C. Nawrocki, M.J. Delorey, A.R. Earley, S.A. Hook, K.J. Kugeler, G.E. Marx, P.S. Mead, A.F. Hinckley); Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee, USA (A.R. Earley)

Main Article

Weighted percentages of case-patients and control-patients with any nonspecific symptom code from the International Classification of Diseases, 10th Revision, Clinical Modification, by month in the year prediagnosis and postdiagnosis, in study of nonspecific symptoms attributable to Lyme disease in high-incidence areas, United States.

Figure 2. Weighted percentages of case-patients and control-patients with any nonspecific symptom code from the International Classification of Diseases, 10th Revision, Clinical Modification, by month in the year prediagnosis and postdiagnosis, in study of nonspecific symptoms attributable to Lyme disease in high-incidence areas, United States.

Main Article

Page created: August 27, 2025

Page updated: November 14, 2025

Page reviewed: November 14, 2025

The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.